Jim Simons Sangamo Therapeutics, Inc Transaction History

Renaissance Technologies LLC

$70.6 Billion
Q2 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 6,839,434 shares of SGMO stock, worth $3.56 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

6,839,434

Previous 3,168,107 115.88%

Holding current value

$3.56 Million

Previous $2.09 Million 76.7%

% of portfolio

0.01%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$0.43 - $0.81 $1.58 Million - $2.97 Million	3,671,327 Added 115.88%	6,839,434 $3.69 Million
Q1 2025 May 14, 2025	BUY	$0.66 - $1.37 $54,931 - $114,025	83,230 Added 2.7%	3,168,107 $2.09 Million
Q4 2024 Feb 13, 2025	SELL	$0.78 - $2.87 $1.38 Million - $5.07 Million	-1,767,900 Reduced 36.43%	3,084,877 $3.15 Million
Q3 2024 Nov 13, 2024	BUY	$0.32 - $1.1 $232,384 - $798,820	726,200 Added 17.6%	4,852,777 $4.17 Million
Q2 2024 Aug 09, 2024	BUY	$0.36 - $0.65 $550,296 - $993,590	1,528,600 Added 58.84%	4,126,577 $1.49 Million
Q1 2024 May 13, 2024	SELL	$0.42 - $1.38 $230,118 - $756,103	-547,901 Reduced 17.42%	2,597,977 $1.74 Million
Q4 2023 Feb 13, 2024	BUY	$0.3 - $0.63 $234,037 - $491,478	780,124 Added 32.98%	3,145,878 $1.71 Million
Q3 2023 Nov 14, 2023	SELL	$0.58 - $1.47 $407,010 - $1.03 Million	-701,742 Reduced 22.88%	2,365,754 $1.42 Million
Q2 2023 Aug 11, 2023	SELL	$1.11 - $1.74 $183,481 - $287,620	-165,299 Reduced 5.11%	3,067,496 $3.99 Million
Q1 2023 May 12, 2023	BUY	$1.66 - $3.67 $1.85 Million - $4.09 Million	1,113,299 Added 52.53%	3,232,795 $5.69 Million
Q4 2022 Feb 13, 2023	BUY	$2.77 - $5.07 $1.26 Million - $2.3 Million	453,400 Added 27.21%	2,119,496 $6.66 Million
Q3 2022 Nov 14, 2022	BUY	$4.27 - $6.39 $967,581 - $1.45 Million	226,600 Added 15.74%	1,666,096 $8.16 Million
Q2 2022 Aug 12, 2022	BUY	$3.28 - $6.21 $2.22 Million - $4.2 Million	676,400 Added 88.64%	1,439,496 $5.96 Million
Q1 2022 May 13, 2022	SELL	$5.23 - $7.82 $458,148 - $685,032	-87,600 Reduced 10.3%	763,096 $4.43 Million
Q4 2021 Feb 11, 2022	BUY	$7.29 - $10.97 $839,778 - $1.26 Million	115,196 Added 15.66%	850,696 $6.38 Million
Q3 2021 Nov 12, 2021	BUY	$9.01 - $12.01 $1.37 Million - $1.83 Million	152,300 Added 26.11%	735,500 $6.63 Million
Q2 2021 Aug 13, 2021	SELL	$10.17 - $12.64 $2 Million - $2.49 Million	-196,600 Reduced 25.21%	583,200 $6.98 Million
Q1 2021 May 13, 2021	SELL	$10.88 - $17.05 $5.58 Million - $8.74 Million	-512,800 Reduced 39.67%	779,800 $9.77 Million
Q4 2020 Feb 10, 2021	SELL	$9.23 - $18.18 $303,583 - $597,958	-32,891 Reduced 2.48%	1,292,600 $20.2 Million
Q3 2020 Nov 13, 2020	BUY	$9.38 - $12.48 $12.4 Million - $16.5 Million	1,325,491 New	1,325,491 $12.5 Million
Q4 2019 Feb 13, 2020	SELL	$8.03 - $11.7 $538,010 - $783,900	-67,000 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$9.05 - $12.22 $5.07 Million - $6.84 Million	-559,800 Reduced 89.31%	67,000 $606,000
Q2 2019 Aug 12, 2019	SELL	$8.75 - $13.03 $2.44 Million - $3.63 Million	-278,400 Reduced 30.76%	626,800 $6.75 Million
Q1 2019 May 14, 2019	BUY	$7.72 - $12.81 $6.99 Million - $11.6 Million	905,200 New	905,200 $8.64 Million

Others Institutions Holding SGMO

# of Institutions

140

Shares Held

55.7M

Call Options Held

2.22M

Put Options Held

1.82M

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $81.4M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account